Suppr超能文献

炎症性肠病的肾脏表现及并发症。

Renal manifestations and complications of inflammatory bowel disease.

机构信息

Department of Gastroenterology, University of Thessaly, School of Medicine, Larissa, Greece.

出版信息

Inflamm Bowel Dis. 2011 Apr;17(4):1034-45. doi: 10.1002/ibd.21468. Epub 2010 Sep 14.

Abstract

Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD) and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis, and glomerulonephritis. Symptoms of renal impairment are not always specific and since the underlying bowel disease is preponderant, renal function deterioration may be underestimated. Additionally, medical treatment of patients with IBD such as aminosalicylates, cyclosporine, and tumor necrosis factor-α inhibitors can cause renal complications, although direct correlation to bowel disease is not always clear. The well-documented renal manifestations and complications of IBD, as well as the possible renal side effects of new drugs, emphasize the need for periodic evaluation of renal function. New markers of renal function may facilitate early diagnosis and unravel the complex mechanisms responsible for kidney damage. The purpose of this review is to summarize the renal manifestations and complications as well as the markers of renal function utilized in IBD, attempting to shed more light on the pathophysiology of renal damage in IBD.

摘要

在炎症性肠病(IBD)患者中,肾脏表现和并发症并不罕见,可能表现为肾结石、淀粉样变性、肾小管间质性肾炎和肾小球肾炎。肾脏损害的症状并不总是具有特异性,而且由于基础肠道疾病占主导地位,肾功能恶化可能被低估。此外,IBD 患者的医学治疗,如氨基水杨酸盐、环孢素和肿瘤坏死因子-α抑制剂,可能会导致肾脏并发症,尽管与肠道疾病的直接相关性并不总是明确。IBD 的肾脏表现和并发症以及新药物可能的肾脏副作用已经有充分的记录,这强调了定期评估肾功能的必要性。新的肾功能标志物可能有助于早期诊断,并揭示导致肾脏损伤的复杂机制。本综述的目的是总结 IBD 中的肾脏表现和并发症以及用于 IBD 的肾功能标志物,试图更深入地了解 IBD 中肾脏损伤的病理生理学。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验